Scientists at St George's, University of London, are working on a blood test that uses DNA markers to identify prostate cancer cells that are shed into the bloodstream.
The researchers have demonstrated that by measuring the levels of these markers, not only can an accurate diagnosis of cancer be made, but the stage the cancer has reached whether it is still localized or already has spread and become metastatic can be identified.
In addition, certain markers, if switched on, will hopefully give information on how quickly the cancer will develop, and, therefore, when treatment must be introduced.
Read full story at Medical News Today.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment